- $437.69m
- $374.53m
Annual balance sheet for Abivax SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | FAS | FAS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 29.3 | 60.7 | 26.9 | 261 | 152 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8.04 | 9.81 | 8.32 | 19.1 | 15.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 37.7 | 75.2 | 36.2 | 286 | 171 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.1 | 0.093 | 1.59 | 0.878 | 2.67 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 71.3 | 110 | 75.5 | 327 | 205 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 32.6 | 28 | 32.1 | 90.7 | 94 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 66.6 | 81.6 | 68.4 | 131 | 165 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.67 | 28.8 | 7.19 | 196 | 40.6 |
| Total Liabilities & Shareholders' Equity | 71.3 | 110 | 75.5 | 327 | 205 |
| Total Common Shares Outstanding |